We are live on ! Find out more
NVRO

NEVRO CORP.

Delisted

NVRO was delisted on the 2nd of April, 2025.

110 hedge funds and large institutions have $1.05B invested in NEVRO CORP. in 2015 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 53 increasing their positions, 15 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 10

253% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 15

83% more capital invested

Capital invested by funds: $574M → $1.05B (+$479M)

75% more funds holding in top 10

Funds holding in top 10: 47 (+3)

38% more funds holding

Funds holding: 80110 (+30)

48% less call options, than puts

Call options by funds: $3.84M | Put options by funds: $7.4M

Holders
110
Holders Change
+30
Holders Change %
+37.5%
% of All Funds
2.95%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.19%
New
40
Increased
53
Reduced
15
Closed
10
Calls
$3.84M
Puts
$7.4M
Net Calls
-$3.56M
Net Calls Change
-$3.56M

NVRO Hedge Fund Activity: Q2 2015 in Review

110 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q2 2015, worth a combined $1.05B — up 83% from $574M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new NVRO positions and 10 closed out — a net gain of 30 holders — while 53 added to existing stakes and 15 trimmed.

The largest buyer was AllianceBernstein, adding an estimated $46.2M. The largest seller was Novo Holdings A/S, cutting an estimated $34.1M.

  • 110 institutional investors held NEVRO CORP. (NVRO) as of Q2 2015, up from 80 in Q1 2015.
  • Funds reported $1.05B of NEVRO CORP. stock for Q2 2015, up 83% quarter-over-quarter.
  • 40 funds opened new NEVRO CORP. positions in Q2 2015 and 10 closed out, a net change of +30 holders.
  • The largest NEVRO CORP. buyer in Q2 2015 was AllianceBernstein, an estimated $46.2M added.
  • The largest NEVRO CORP. seller in Q2 2015 was Novo Holdings A/S, an estimated $34.1M sold.

Based on aggregated 13F filings for Q2 2015.